Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation

Transplantation

Volumn 66, Issue 12, 1998, Pages 1694-1697

  Ali, Muhammad K ^a   Light, Jimmy A ^a   Barhyte, Diana Y ^a   Sasaki, Truman M ^a   Currier Jr , Charles B ^a   Grandas, Oscar ^a   Fowlkes, Deneen ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; FEMALE; GRAFT REJECTION; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 0032573741     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812270-00021     Document Type: Article

References (14)

1. Pereira BJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454.
2. Mahony JF. Long term results and complications of transplantation: the kidney. Transplant Proc 1989; 21: 1433.
3. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1991; 51: 981.
4. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating anti-bodies to a major etiologic virus of human non-A, non-B hepatitis virus. Science 1989; 244: 362.
5. Pereira BJG. Hepatitis C in organ transplantation: its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens 1993; 2: 912.
6. Stempel CA, Lake J, Kuo G, Vincent F. Hepatitis C: its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273.
7. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1995; 45: 238.
8. Ynares C, Johnson HK, Kerlin T, Crowe D, MacDonell R, Richie R. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival: a 5- and 10-year follow-up. Transplant Proc 1993; 25: 1283.
9. Fritsche C, Brandes JC, Delaney SR, et al. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993; 55: 1283.
10. Pereira BJG, Wright TL, Schmid CH, Levey AS. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 799.
11. Genesca J, Vila J, Cordoba J, et al. Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication. J Hepatol 1995; 22: 272.
12. Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667.
13. Ponz E, Campistol JM, Bruguera M, et al. Hepatitis C virus infection among kidney transplant recipients. Kidney Int 1991; 40: 748.
14. Roth D. Hepatitis C virus: the nephrologist's view. Am J Kidney Dis 1995; 25: 3.